PURE Bioscience, Inc. announced earnings results for the third quarter ended April 30, 2020. For the third quarter, the company announced operating income was USD 474,000 compared to operating loss of USD 912,000 a year ago. Net income was USD 473,000 compared to net loss of USD 1.873 million a year ago. Basic earnings per share from continuing operations was USD 0.01 compared to basic loss per share from continuing operations of USD 0.03 a year ago. For the nine months, operating loss was USD 1.319 million compared to USD 4.767 million a year ago. Net loss was USD 1.318 million compared to USD 5.735 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.08 a year ago.